These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7176148)

  • 1. [Clinical investigation of serum group I pepsinogen (PG I) by radioimmunoassay].
    Nakanome C; Akai H; Goto Y
    Nihon Shokakibyo Gakkai Zasshi; 1982 Aug; 79(8):1568-75. PubMed ID: 7176148
    [No Abstract]   [Full Text] [Related]  

  • 2. Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients.
    Plebani M; Di Mario F; Vianello F; Giordano A; Masiero M; Lazzaretto M; Farini R; Ceriotti G; Naccarato R
    Clin Biochem; 1983 Feb; 16(1):20-2. PubMed ID: 6861334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
    Samloff IM; Liebman WM; Panitch NM
    Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental evaluation of an IRMA assay kit for pepsinogen I and II].
    Kimura Y; Ata M; Miyagawa N; Fujii T; Tanada S; Iio A; Hamamoto K
    Kaku Igaku; 1989 Sep; 26(9):1217-21. PubMed ID: 2810916
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum pepsinogen: correlation of techniques and analysis of levels found in different diseases of the stomach and duodenum.
    Sáez-Alquézar A; Marchese MA; Bezerra TV; Andreoli JC; Parra DS; Pontes JF
    Clin Chim Acta; 1978 Dec; 90(2):163-9. PubMed ID: 719900
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of pepsinogen analysis in clinical tests].
    Miki K
    Nihon Rinsho; 1989 Dec; 48 Suppl():324-6. PubMed ID: 2621894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of serum group I pepsinogen level in gastric duodenal diseases].
    Noguchi M; Nakajima K; Yoshii M; Kono S; Aoki E; Tanaka K; Adachi H; Torizuka K
    Nihon Shokakibyo Gakkai Zasshi; 1983 Feb; 80(2):131-9. PubMed ID: 6865060
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage.
    Tanaka Y; Mine K; Nakai Y; Mishima N; Nakagawa T
    Gut; 1991 Aug; 32(8):849-52. PubMed ID: 1885064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An enzyme-linked immunosorbent assay of serum group I pepsinogen using a monoclonal antibody and its clinical application].
    Huang SC; Miki K; Shimizu A; Ichinose M; Oka H; Furihata C; Matsushima T; Hirano K; Hayashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jan; 84(1):13-9. PubMed ID: 3573381
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma pepsinogen in health and gastroduodenal disorders.
    Naganna B; Balasundaram D; Venkaiah KR
    J Indian Med Assoc; 1972 Jan; 58(1):6-9. PubMed ID: 5021272
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.
    Ichinose M; Miki K; Furihata C; Kageyama T; Hayashi R; Niwa H; Oka H; Matsushima T; Takahashi K
    Clin Chim Acta; 1982 Dec; 126(2):183-91. PubMed ID: 7151278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder.
    Rotter JI; Sones JQ; Samloff IM; Richardson CT; Gursky JM; Walsh JH; Rimoin DL
    N Engl J Med; 1979 Jan; 300(2):63-6. PubMed ID: 758579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy.
    Matsushima M; Miki K; Ichinose M; Kakei N; Yahagi N; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
    Adv Exp Med Biol; 1995; 362():131-7. PubMed ID: 8540311
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers.
    Biemond I; Crobach LF; Jansen JB; Lamers CB
    Br J Clin Pharmacol; 1990 Apr; 29(4):465-72. PubMed ID: 2328194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
    Park SM; Park J; Chang SK; Yoo BC; Kim HJ
    Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum pepsinogen I levels in bleeding duodenal ulcer].
    Kolster JJ; Castro de Kolster C; Macía de Luco M
    G E N; 1990; 44(2):118-24. PubMed ID: 2152265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of duodenal ulcer and elevated serum pepsinogen I levels in smokers and nonsmokers.
    Sumii K; Kimura M; Morikawa A; Haruma K; Yoshihara M; Kajiyama G
    Am J Gastroenterol; 1990 Nov; 85(11):1493-7. PubMed ID: 2239877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
    Samloff IM; Stemmermann GN; Heilbrun LK; Nomura A
    Gastroenterology; 1986 Mar; 90(3):570-6. PubMed ID: 3943688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pepsinogens, pepsins, and peptic ulcer.
    Samloff IM; Taggart RT
    Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of pepsinogen group I in endoscopic gastroduodenal biopsies.
    Plebani M; Di Mario F; Dal Santo PL; Faggian D; Germana B; Vianello F; Naccarato R; Burlina A
    Clin Chem; 1990 Apr; 36(4):682-4. PubMed ID: 2323049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.